logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Enrique Perez-Paya

This inventor holds 6 USPTO granted patents. Top assignees: Torrey Pines Institute for Molecular Studies, Fibrostatin, S.l.. Active years: 1996-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Enrique Perez-Paya. Retrieved from https://idiyas.com/inventor/enrique-perez-paya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 83.3

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 20(Granted Patents)


Location History:

  • San Diego, CA (US) (1996 - 1998)
  • Valencia, ES (1998 - 2013)

Company Filing History:

goldMedal5 out of 45 
 
Torrey Pines Institute for Molecular Studies
 patents
silverMedal1 out of 1 
 
Fibrostatin, S.l.
 patent

Years Active: 1996-2013

Loading Chart...
6 patents (USPTO):Explore Patents
1. 8586776 - [object Object] (2013-11-19),
2. 5840697 - Peptide inhibitors of calmodulin (1998-11-24),
3. 5814470 - Melittin-related polypeptides, mixture sets and libraries thereof (1998-09-29),
4. 5645996 - Melittin-related polypeptides, mixture sets and libraries thereof (1997-07-08),
5. 5624902 - Peptide inhibitors of calmodulin (1997-04-29),
6. 5582997 - Lysine/leucine polypeptides, mixture sets and libraries thereof (1996-12-10),

Title: Innovations of Inventor Enrique Perez-Paya

Introduction

Enrique Perez-Paya is a notable inventor based in San Diego, CA. He has made significant contributions to the field of therapeutics, particularly in the development of compounds that inhibit GPBP activity and calmodulin. With a total of 6 patents, his work has the potential to impact various medical conditions.

Latest Patents

Among his latest patents, one focuses on compounds that inhibit GPBP activity, making them useful in treating antibody-mediated disorders, drug-resistant cancer, inflammation, protein misfolding, ER stress-mediated disorders, and aberrant apoptosis. Another significant invention involves a novel family of peptides that inhibit calmodulin, which can be utilized in pharmaceutical compositions to treat calmodulin-related disorders.

Career Highlights

Enrique has worked with esteemed organizations such as Torrey Pines Institute for Molecular Studies and Fibrostatin, S.L. His experience in these institutions has allowed him to advance his research and contribute to innovative solutions in the medical field.

Collaborations

He has collaborated with notable colleagues, including Sylvie E Blondelle and Richard Allen Houghten. Their combined expertise has fostered advancements in their respective research areas.

Conclusion

Enrique Perez-Paya's innovative work and patents reflect his dedication to improving therapeutic options for various medical conditions. His contributions continue to influence the field of biomedical research and therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…